Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reticuloendothelial system function test using 131I-labeled aggregated albumin.

E Ouchi, K Miura, S Yamagata

    The Tohoku Journal of Experimental Medicine
    |June 1, 1975
    PubMed
    Summary

    This study evaluates a method for testing the function of the reticuloendothelial system, which is part of the immune system, using a radioactive tracer. By measuring how the body breaks down this tracer in the blood, researchers assessed liver health in patients with various conditions. The results show that certain liver diseases lead to specific changes in how this tracer is processed, offering a potential new way to monitor organ function.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Predictive value of major adverse cardiac events by T2-mapping texture analysis of the myocardial remote zone in patients with acute myocardial infarction.

    Clinical radiology·2022
    Same author

    Clinical and prognostic significance of bone marrow abnormalities in the appendicular skeleton detected by low-dose whole-body multidetector computed tomography in patients with multiple myeloma.

    Blood cancer journal·2015
    Same author

    Increased oxidized form of human serum albumin in patients with diabetes mellitus.

    Diabetes research and clinical practice·1992
    Same author

    Successful pancreatojejunal anastomosis for pancreatoduodenectomy.

    Surgery, gynecology & obstetrics·1992
    Same author

    Differential macrophage-mediated cytotoxicity to P388 leukemia cells and its drug-resistant cells examined by a new MTT assay.

    Leukemia research·1992
    Same author

    A cylinder-shaped balloon catheter for the management of dissecting aneurysms in acute stage.

    Herz·1992

    Area of Science:

    • Clinical diagnostic research within the reticuloendothelial system field
    • Gastroenterology and hepatology diagnostics

    Background:

    No prior work had resolved the optimal approach for assessing clearance capabilities within the human immune network. Prior research has shown that radioactive particles can serve as indicators for organ-specific activity. That uncertainty drove the need for standardized diagnostic protocols using readily available tracers. It was already known that specific proteins are processed by specialized cells in the liver. This gap motivated the exploration of using standard imaging agents for functional assessment. Prior studies often required high concentrations of materials that were difficult to obtain for routine clinical use. Researchers sought to determine if lower doses could provide meaningful physiological insights. This study addresses the limitations of previous diagnostic techniques by utilizing existing medical supplies.

    Purpose Of The Study:

    The aim of this research is to evaluate the utility of a specific radioactive tracer for assessing the functional capacity of the reticuloendothelial system. Investigators sought to determine if commercially available imaging agents could provide reliable data on hepatic metabolic performance. The study addresses the challenge of measuring phagocytic activity without relying on high-dose protocols that may interfere with natural physiological processes. Researchers focused on the catabolic breakdown of labeled albumin by Kupffer cells in the liver. This investigation was motivated by the need for a more precise diagnostic tool for patients with various hepatic disorders. The team explored whether the ratio of ionic to protein-bound tracer in the plasma could serve as a valid indicator of disease. By examining this ratio, the authors intended to clarify the relationship between cellular metabolism and clinical liver status. This work provides a foundation for understanding how standard tracers can be repurposed for functional diagnostics.

    Keywords:
    Kupffer cellsradioactive tracermetabolic activitydiagnostic imagingplasma chromatography

    Frequently Asked Questions

    The researchers propose that the catabolic activity of Kupffer cells is the primary mechanism. By measuring the ratio of ionic iodine to protein-bound albumin in plasma sixty minutes post-injection, they determine the rate at which the immune system processes the tracer particles.

    The team utilized 131I-labeled aggregated human albumin, commonly employed for liver scintiscanning. This specific tracer allows for the tracking of phagocytic activity without requiring the high doses typically associated with older, more invasive diagnostic procedures.

    A dose lower than the critical threshold is necessary to focus exclusively on the catabolic breakdown of the tracer by liver cells. Using smaller amounts prevents the saturation of phagocytic pathways, ensuring that the measured results reflect natural metabolic rates rather than overloaded clearance systems.

    Related Experiment Videos

    Main Methods:

    The review approach involved evaluating the metabolic processing of radioactive particles in human subjects. Investigators utilized commercially available albumin tracers originally intended for imaging purposes. The team performed plasma collection exactly one hour after the intravenous administration of the labeled particles. Laboratory staff employed gel column chromatography to separate the resulting blood components into distinct fractions. This analytical technique allowed for the identification of two separate peaks representing different chemical states. Researchers calculated the specific ratio between these ionic and protein-bound fractions to quantify metabolic activity. The study compared these calculated values across various patient groups to identify potential diagnostic patterns. This design focused on assessing the catabolic performance of specialized hepatic cells rather than standard clearance rates.

    Main Results:

    Key findings from the literature indicate that the F/B ratio is significantly reduced in patients diagnosed with liver cirrhosis or hepatoma. The data show that these specific disease states exhibit lower metabolic processing compared to the control group. The researchers observed that this ratio does not correlate with standard liver function markers or clinical findings. Furthermore, the results demonstrate no statistical relationship between the F/B ratio and the Congo red index. The study highlights that the tracer breakdown occurs within Kupffer cells after phagocytosis. Measurements were derived from plasma samples collected sixty minutes post-injection. The analysis confirmed that the separation of ionic and protein-bound components is achievable via column chromatography. These findings suggest that the metabolic activity of the liver can be assessed using lower doses of imaging tracers.

    Conclusions:

    The authors propose that the ratio of tracer components serves as a unique indicator of hepatic metabolic health. This metric reflects the processing capacity of specialized liver cells rather than simple blood flow. The researchers suggest that this test provides information distinct from standard clinical evaluations. Synthesis and implications indicate that the measured ratio remains independent of traditional liver function markers. The team notes that their findings do not align with existing clearance tests like the Congo red index. These observations imply that the current method captures a different aspect of physiological performance. The study concludes that this approach offers a novel perspective on liver pathology. Future applications may focus on refining the interpretation of these metabolic signals in diverse patient populations.

    Gel column chromatography acts as the primary tool for separating the plasma samples. This technique effectively isolates the ionic iodine from the protein-bound albumin, allowing for the precise calculation of the F/B ratio used to compare healthy subjects against those with liver disease.

    The researchers measured the F/B ratio, which represents the proportion of ionic iodine to protein-bound albumin. This value was significantly lower in patients with liver cirrhosis and hepatoma compared to the control group, indicating impaired metabolic processing in these specific hepatic conditions.

    The authors claim that this diagnostic ratio does not correlate with traditional liver function tests or hepatic scintiscanning results. They suggest that this lack of correlation highlights the unique nature of the information provided by their metabolic assessment method.